Algatech Opens New US Subsidiary

5760b5a2-7a62-4840-89fd-f0780c78c6adarticleimage.jpg

15 Jun 2017 --- Algatech has opened Algatech Inc., a New York City-based subsidiary created to serve its customers in the North American market. The company is appointing Ken Seguine to lead the new operation. Algatech’s expansion into the US will accelerate development of the growing market in North America for its leading microalgae ingredient brand, AstaPure, as well as new microalgae sources in the pipeline. 

Algatech Inc.’s responsibilities will include the US, Canada and Mexico. Gary Brenner, who was responsible for Algatech’s business development in the NAFTA markets since 2010, will lead the algal protein development project as part of the European Institute of Innovation and Technology consortium (EIT Food).

Click to EnlargeSpeaking about the company’s growth, Efrat Kat, ‎VP Marketing & Sales at Algatechnologies, tells NutritionInsight that “in the last six months or so we recruited an entire team of R&D people, including a head of business development who will focus on new product development. We are expanding our team, but also our presence in the market. We are looking to recruit more people for our team, and we are also conducting more clinical studies for our astaxanthin and other products.”

“[Algatech] has the know-how, the experience and the right infrastructure and locations, there is still a lot of potential untapped in the microalgae industry and we are fascinated about further developing this industry,” Kat says.

Ken Seguine served as VP Sales and Marketing of UAS Laboratories 2013-2017 and was Executive VP consumer products at Savesta Life Sciences Inc. He brings more than 25 years of experience in the natural products industry with companies in both dietary supplements and personal care.

“We are committed to expanding our global marketing network and strengthening our presence in the NAFTA markets,” says Algatech CEO Hagai Stadler. “This includes highly qualified personnel recruitment, new product developments, and growing Algatech’s operation facilities in the Arava desert, Israel.”

“I’m excited to join the team at Algatech and help them better serve the North American market with our new organic and non-GMO ingredients,” says Seguine. “Algatech specializes in the development and production of ingredients derived from algae. I am looking forward to contributing my background in organic agriculture, cosmetics and dietary supplements to the company’s activities.”

Click to EnlargeAlgatech was chosen by the EIT’s Knowledge and Innovation Communities (KIC) leaders to be the sole algae producer, especially to develop new food sources from microalgae via its advanced technologies and capabilities. Algatech intends to invest heavily in developing plant-based protein from microalgae in cooperation with global ingredient companies.

“Algatech is focused on natural microalgae solutions,” says Stadler. “It cultivates microalgae in a patented, eco-friendly, closed system that allows the production of safe, pure ingredients and minimize its environmental footprint. The company works relentlessly to unlock the potential of microalgae, discovering and industrializing new strains of microalgae, and producing it in large scale through methods completely beneficial to both consumers and the planet.”

To contact our editorial team please email us at editorial@cnsmedia.com

Algatechnologies Ltd.

Collapse

Algatechnologies is a rapidly growing biotechnology company, specializing in the commercial cultivation of microalgae. Founded in 1998, Algatech is a world leader in the production and supply of AstaPure®, a premium natural astaxanthin - one of the world’s most powerful antioxidants sourced from the microalga Haematococcus pluvialis. 

Located in Israel's Arava desert – with its stable climate and high light intensity – Algatechnologies is ideally positioned to cultivate algae. The company produces astaxanthin in an innovative process, and markets its AstaPure® brand to the nutrition, food & beverages and cosmetics industries. 

Algatechnologies enjoys a global presence through a well-established marketing network of selected distributors and agents. The company's sales organization serves more than 30 countries, via an extensive network of exclusive distributors and by direct sales to multi-national customers. The company provides logistics, warehousing and lab support services, offering customers reliable supply and prompt response. 

Algatechnologies' objectives are:

To provide the highest quality of natural astaxanthin, backed by experienced technical and marketing support.

To continue developing, producing and commercializing advanced algal-based products to the fastest growing markets by utilizing proprietary algal cultivation and processing technologies. 

Related Articles

Nutrition & Health News

Algatech introduces new algae strain in “milestone” for microalgae industry

04 Jun 2018 --- Algatechnologies (Algatech) has launched Fucovital, a patented, “all natural,” three percent fucoxanthin oleoresin produced and extracted from microalgae. Fucovital also touts being the first fucoxanthin product granted New Dietary Ingredient Notification (NDIN) acknowledgment for dietary supplements from the Food and Drug Administration (FDA). Algatech claims to have developed a “unique” extraction process that overcomes previous barriers to the microalgae ingredient's commercialization.

Nutrition & Health News

Algalif seeks Asia-Pacific market growth with Astaxanthin ingredients and introduction of finished products

28 May 2018 – Algalif, Icelandic producer of astaxanthin ingredients and finished products from microalgae, is expanding into the Asia-Pacific market with its Astalif astaxanthin oleoresins, and the launch of its IceCaps astaxanthin soft gelatin capsules. In addition, the company has launched its Icelandic Harvest brand of finished astaxanthin products in response to retail trade demand.

Nutrition & Health News

Marealis’ novel shrimp peptide gains EFSA green light

22 May 2018 --- The European Food Safety Authority (EFSA) has approved an application for the novel food status of a shrimp peptide concentrate, meaning that the ingredient can now be utilized in EU supplement applications. The application was made by the company Medfiles Ltd. on behalf of Marealis, a developer of science-backed nutraceuticals. The supplements will be marketed to those who want to address the problem of prehypertension in the Marealis product, PreCardix.

Nutrition & Health News

BGG & Solix Algredients combine to expand functional ingredient NPD and portfolio

18 May 2018 --- BGG and Solix Algredients, Inc. have joined forces to form a new company supplying functional ingredients originating from three sectors: algae, fruits and plants. The new company hopes for particular strength in innovative product combinations and the natural astaxanthin market. The portfolio will include natural astaxanthin, DHA Omega-3 fatty acids, Vitamin E tocotrienols, apple polyphenols and fruit/berry extracts for the food/beverage, personal care and feed markets. 

Nutrition & Health News

Innovating microalgae: Algatech partners with encapsulation firm on delivery forms

09 May 2018 --- Algatechnologies (Algatech) is teaming up with Italian R&D company Sphera Encapsulation to develop innovative, functional ingredient formats. Based on Sphera’s propriety encapsulation technology, the partnership is to focus first on the development of innovative new delivery forms of ingredients derived from microalgae, starting with a water-soluble powder of all-natural astaxanthin.

More Articles
URL : http://www.nutritioninsight.com:80/news/algatech-opens-new-us-subsidiary.html